ASCPT 2019

      Date
      Mar 13, 2019 - Mar 16, 2019
      Location
      Washington, D.C.

      The 2019 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) will take place at the Marriott Wardman Park in Washington, DC. The ASCPT Annual Meeting is the premier scientific event for scientists in clinical pharmacology and translational medicine. The theme of the 2019 Annual Meeting is From Molecule to Patient. The Scientific Program Committee, chaired by Piet H. van der Graaf, PhD, PharmD, has organized a cutting-edge program that addresses emerging clinical pharmacology and translational medicine issues that span the continuum of drug discovery, development, regulation, and utilization. The exciting line-up includes two outstanding Pre-Conference programs— PBPK Modeling for the Development and Approval of Locally Acting Drug Products and Advancing QSP Toward Predictive Drug Development: From Targets to Treatments.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.